In Depth Computational Screening of Novel Indane-۱, ۳-Dione Derivatives as Potential Anti-Tubercular Agents

Publish Year: 1403
نوع سند: مقاله ژورنالی
زبان: Persian
View: 31

This Paper With 31 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_AJCS-7-5_007

تاریخ نمایه سازی: 27 خرداد 1403

Abstract:

Mycobacterium TB poses a significant challenge by developing resistance to currently available medications, making it a serious global health concern. Therefore, it is imperative to create novel medications that exhibit efficacy against diverse strains of Tuberculosis. Isoniazid (INH) is a primary anti-tubercular medication that works against Mycobacterium TB by blocking the activity of a specific enzyme called InhA, which is responsible for reducing a compound called ۲-trans-enoyl-acyl carrier protein. The aim of this study was to pinpoint novel inhibitors of the enoyl-acyl carrier protein (ACP) reductase InhA. This work specifically examines the use of in silico techniques molecular docking and molecular dynamic simulation to study designed substituted Indane-۱, ۳ dione derivatives (۱-۱۵). The In silico ADMET screening was conducted using the SwissADME and admet SAR online ADME prediction tool server and passes Lipinski’s rule of five as well as pharmacokinetic features like skin permeability and molar refractivity lies with in limit which shows none of noticeable signs of toxicity. The stability of the docked complex was assessed by conducting a Molecular Dynamics (MD) simulation using Schrodinger Desmond over ۱۰۰ ns. Most of the residues in the root mean square fluctuation (RMSF) fell between the range of ۰.۵-۴ Å and radius of gyration ranges between ۱۸.۱ to ۱۸.۴ Å throughout the ۱۰۰ ns simulation reflects maintaining stability of protein complex during the catalytic activity. Most of compounds shows higher GI absorption and inhibits CYP-۳A۴, CYP-۲D۶, CYP promiscuity shows range from ۰.۵-۰.۹. Compound ۱۱ have highest docking score of -۱۰.۳۸ kcal/mol and shows excellent hydrophobic and hydrophilic interactions with most of amino acid residues. Moreover, compound ۱۱ were found to be safe for acute inhalation and cutaneous sensitization. Thus, the obtained results suggest that compound ۱۱, ۲-[(trifluoromethyl) phenyl] methylidene-۱H-indene-۱, ۳(۲H)-dione appear to be good candidates for drugs with a potential leading structure for further development.

Authors

Nitin Arjun Londhe

School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, ۶۰۰۱۱۷, India

Karthickeyan Krishnan

Department of Pharmacy Practice, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies (VISTAS), Pallavaram, Chennai, Tamil Nadu, ۶۰۰۱۱۷, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • K. Mehta, P. Sharma, S. Mujawar, A. Vyas, Role of ...
  • A. Wang, N. Du, H. Song, Y. Zhang, X. Zhong, ...
  • M. Pai, T. Kasaeva, S. Swaminathan, Covid-۱۹’s devastating effect on ...
  • T.A. Jhaveri, C. Fung, A.N. LaHood, A. Lindeborg, C. Zeng, ...
  • W.H.O. World Tuberculosis Report ۲۰۲۳; World Health Organization: Geneva, Switzerland, ...
  • T.M. Daniel, The history of tuberculosis, Respiratory Medicine, ۲۰۰۶, ۱۰۰, ...
  • B. Şahin, G. İlgün, Risk factors of deaths related to ...
  • G. Van Den Berg, W.T. Nauta, Effects of anti-inflammatory ۲-aryl-۱, ...
  • D. Menzies, Canadian Tuberculosis Standards ۸th edition: What’s new? And ...
  • D. Falzon, M. Zignol, M. Bastard, K. Floyd, T. Kasaeva, ...
  • J.C. Emery, A.S. Richards, K.D. Dale, C.F. McQuaid, R.G. White, ...
  • H.I. Boshoff, D.F. Warner, B. Gold, Drug-resistant Mycobacterium tuberculosis, Frontiers ...
  • D. Vishwakarma, A. Gaidhane, S. Sahu, A.S. Rathod, Multi-drug resistance ...
  • M.A. Behr, P.H. Edelstein, L. Ramakrishnan, Is Mycobacterium tuberculosis infection ...
  • H.S. Cox, M. Morrow, P.W. Deutschmann, Long term efficacy of ...
  • W.H. Organization, S.T. Initiative, Treatment of tuberculosis: guidelines, World Health ...
  • M.V.N.d. Souza, T.R.A. Vasconcelos, Fármacos no combate à tuberculose: passado, ...
  • World Health Organization. Global tuberculosis report ۲۰۱۸, Genève, Switzerland: World ...
  • J.I. Silesky-Jiménez, Tuberculosis Multidrug Resistance (MDR-TB), Highly Infectious Diseases in ...
  • M. Daffé, P. Draper, The envelope layers of mycobacteria with ...
  • J. Pawełczyk, L. Kremer, The molecular genetics of mycolic acid ...
  • P.S. Phatak, R.D. Bakale, S.T. Dhumal, L.K. Dahiwade, P.B. Choudhari, ...
  • S.R. Luckner, N. Liu, C.W. Am Ende, P.J. Tonge, C. ...
  • S. Thapa, M.S. Biradar, S.L. Nargund, I. Ahmad, M. Agrawal, ...
  • S.S. Rani, Shivaraj, Subhashini, Design, synthesis and pharmacological evaluation of ...
  • T. Nishiyama, S. Shiotsu, H. Tsujita, Antioxidative activity and active ...
  • G. Van Den Berg, W.T. Nauta, Effects of anti-inflammatory ۲-aryl-۱, ...
  • R.M. Houben, P.J. Dodd, The global burden of latent tuberculosis ...
  • F. Chen, L. Liu, Z. Bai, T. Zhang, K. Zhao, ...
  • V.V. Dhayabaran, T.D. Prakash, R. Renganathan, E. Friehs, D.W. Bahnemann, ...
  • C.B. Mishra, A. Manral, S. Kumari, V. Saini, M. Tiwari, ...
  • B. Bano, K.M. Khan, F. Begum, M.A. Lodhi, U. Salar, ...
  • C.G. Thomson, K. Duncan, S.R. Fletcher, I.T. Huscroft, G. Pillai, ...
  • F. Köhler, K. Fickentscher, U. Halfmann, H. Koch, Embryotoxicity and ...
  • D.R. Buckle, N.J. Morgan, J.W. Ross, H. Smith, B.A. Spicer, ...
  • M. Jeyachandran, P. Ramesh, Synthesis, antimicrobial, and anticoagulant activities of ...
  • S.L. Shapiro, K. Geiger, L. Freedman, Indandione anticoagulants, The Journal ...
  • K. Raval, T. Ganatra, Basics, types and applications of molecular ...
  • S. Tiwari, K. Prakash, Unrevealing the complex interplay: Molecular docking: ...
  • S.A.A. Anand, C. Loganathan, K. Saravanan, S. Kabilan, Comparison of ...
  • L. Orellana, Large-scale conformational changes and protein function: Breaking the ...
  • H. Geng, F. Chen, J. Ye, F. Jiang, Applications of ...
  • L.M. Mihalovits, G.G. Ferenczy, G.M. Keserű, Mechanistic and thermodynamic characterization ...
  • D. Lau, W. Jian, Z. Yu, D. Hui, Nano-engineering of ...
  • S.K. Halder, F. Elma, In silico identification of novel chemical ...
  • S. Dallakyan, A.J. Olson, Small-molecule library screening by docking with ...
  • T.A. Halgren, Identifying and characterizing binding sites and assessing druggability, ...
  • A.K. Rappé, C.J. Casewit, K. Colwell, W.A. Goddard III, W.M. ...
  • B. Adegoke Afeez, M. Adeleke, A. Habeeb, Statistical analysis of ...
  • G.M. Sastry, M. Adzhigirey, T. Day, R. Annabhimoju, W. Sherman, ...
  • A. Mollica, G. Zengin, S. Durdagi, R.E. Salmas, G. Macedonio, ...
  • W.L. Jorgensen, D.S. Maxwell, J. Tirado-Rives, Development and testing of ...
  • A. Adegoke, T. Oyelowo, J. Sanusi, Computational Studies of ۱, ...
  • A.C. Wallace, R.A. Laskowski, J.M. Thornton, LIGPLOT: a program to ...
  • B. Yazdani, H. Sirous, S. Brogi, V. Calderone, Structure-based high-throughput ...
  • Y. Yue, S. Zhao, Y. Sun, X. Yan, J. Liu, ...
  • W.L. Jorgensen, J. Chandrasekhar, J.D. Madura, R.W. Impey, M.L. Klein, ...
  • W.G. Hoover, Canonical dynamics: Equilibrium phase-space distributions, Physical review A, ...
  • G.J. Martyna, D.J. Tobias, M.L. Klein, Constant pressure molecular dynamics ...
  • U. Essmann, L. Perera, M.L. Berkowitz, T. Darden, H. Lee, ...
  • A.B. Adegoke, R.A. Adepoju, A.T.-A. Khan, Molecular Dynamic (MD) Simulation ...
  • R. Girase, I. Ahmad, H. Patel, Bioisosteric modification of Linezolid ...
  • V.R. Jagatap, I. Ahmad, D. Sriram, J. Kumari, D.K. Adu, ...
  • C.A. Lipinski, Lead-and drug-like compounds: the rule-of-five revolution, Drug Discovery ...
  • D. Cao, J. Wang, R. Zhou, Y. Li, H. Yu, ...
  • D.E. Pires, T.L. Blundell, D.B. Ascher, pkCSM: predicting small-molecule pharmacokinetic ...
  • H. Yang, C. Lou, L. Sun, J. Li, Y. Cai, ...
  • A. Adegoke, A.G. Olatunji, L.I. Ajerogba, I. Musa, Theoretical studies ...
  • J.V. Borba, V.M. Alves, R.C. Braga, D.R. Korn, K. Overdahl, ...
  • نمایش کامل مراجع